Skip to main content

Table 2 Hemodynamics parameters and biological investigations during TTE exam

From: Automated left atrial strain analysis for predicting atrial fibrillation in severe COVID-19 pneumonia: a prospective study

Hemodynamic

 HR, bpm

82 [71–90]

78 [59–103]

0.66

 SAP, mmHg

128 [115–138]

120 [110–131]

0.11

 DAP, mmHg

65 [59–73]

62 [53–71]

0.27

 MAP, mmHg

86 [76–94]

85 [71–91]

0.46

 SpO2, %

93 [91–96]

93 [91–96]

0.74

 T, °Celcius

37.6 [36.7–38.3]

36.8 [36.4–37.7]

0.07

SOFA score during TTE

3 [2–5]

5 [3–10]

0.002

SOFA cardiovascular score during TTE

0 [0–1]

4 [1–4]

0.0001

Critical group (n = 25)

 Norepinephrine use, n (%)

14 (22)

11 (69)

< 0.001

  Norepinephrine (ug/Kg/min)

0.26 [0.12–0.96]

0.15 [0.12–0.28]

0.56

 Mechanical ventilation, n (%)

25 (41)

13 (81)

0.005

  PEEP (cmH 2 O)

10 [7–12]

11 [9–14]

0.73

 PaO2, mmHg

79 [65–98]

87 [68–120]

0.96

Biological investigations

 WBC, mm−3

9000 [6100–12900]

7300 [5850–13525]

0.47

 Lymphocyte count, mm−3

700 [400–1250]

800 [300–1100]

0.84

 Hemoglobin, g l−1

12.6 [11.1–13.4]

12.0 [11.4–13.6]

0.90

 C reactive protein, mg l−1

132 [97–220]

152 [144–195]

0.52

 Creatinin, umol l−1

71 [58–90]

82 [56–154]

0.23

 Troponine Tc HS, ng ml−1

18 [6–42]

48.5 [3.25–148]

0.48

 BNP, pg ml−1

66 [42–123]

119 [40–185]

0.42

  1. Bold indicates P < 0.05
  2. Continuous variables are expressed as median [interquartile range]
  3. BNP brain natriuretic peptide, COPD chronic obstructive pulmonary disease, DAP diastolic arterial pressure, HR heart rate, MAP mean arterial pressure, PEEP positive end-expiratory pressure, SAP systolic arterial pressure, SOFA sequential organ failure assessment, Sp02 pulse saturation of oxygen, TTE transthoracic echocardiography, WBC white blood cell